Nykredit A S Takes Position in Welltower Inc. $WELL

Nykredit A S purchased a new stake in Welltower Inc. (NYSE:WELL) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 372,430 shares of the real estate investment trust’s stock, valued at approximately $84,530,000.

A number of other institutional investors have also recently added to or reduced their stakes in WELL. Brighton Jones LLC boosted its stake in Welltower by 7.1% during the fourth quarter. Brighton Jones LLC now owns 4,185 shares of the real estate investment trust’s stock worth $527,000 after buying an additional 279 shares during the period. Empowered Funds LLC lifted its position in shares of Welltower by 31.7% during the 1st quarter. Empowered Funds LLC now owns 14,790 shares of the real estate investment trust’s stock worth $2,266,000 after purchasing an additional 3,564 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in Welltower by 7.1% in the second quarter. Sivia Capital Partners LLC now owns 1,910 shares of the real estate investment trust’s stock valued at $294,000 after purchasing an additional 127 shares in the last quarter. Baird Financial Group Inc. boosted its stake in Welltower by 7.3% in the second quarter. Baird Financial Group Inc. now owns 10,871 shares of the real estate investment trust’s stock valued at $1,671,000 after acquiring an additional 735 shares in the last quarter. Finally, NewEdge Advisors LLC increased its stake in Welltower by 27.0% in the second quarter. NewEdge Advisors LLC now owns 12,435 shares of the real estate investment trust’s stock valued at $1,912,000 after purchasing an additional 2,641 shares during the period. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Welltower Stock Down 0.6%

WELL opened at $238.93 on Thursday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 3.16 and a current ratio of 3.16. The stock’s fifty day moving average is $236.84 and its 200-day moving average is $218.43. Welltower Inc. has a one year low of $163.75 and a one year high of $255.20. The company has a market capitalization of $172.20 billion, a PE ratio of 109.60, a P/E/G ratio of 1.15 and a beta of 0.76.

Welltower (NYSE:WELL) last announced its earnings results on Monday, July 27th. The real estate investment trust reported $0.61 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.05). Welltower had a return on equity of 3.56% and a net margin of 12.15%.The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.40 billion. During the same quarter in the previous year, the business earned $1.28 earnings per share. The business’s quarterly revenue was up 39.1% compared to the same quarter last year. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. On average, equities analysts predict that Welltower Inc. will post 6.43 EPS for the current fiscal year.

Welltower Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Stockholders of record on Wednesday, August 12th were issued a dividend of $0.85 per share. The ex-dividend date of this dividend was Wednesday, August 12th. This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.4%. This is a positive change from Welltower’s previous quarterly dividend of $0.74. Welltower’s payout ratio is currently 155.96%.

Insider Activity at Welltower

In other Welltower news, Director Andrew Gundlach purchased 5,000 shares of the stock in a transaction dated Tuesday, August 25th. The shares were bought at an average cost of $239.47 per share, with a total value of $1,197,350.00. Following the completion of the transaction, the director owned 25,000 shares in the company, valued at $5,986,750. This trade represents a 25.00% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.37% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on WELL shares. UBS Group increased their target price on shares of Welltower from $249.00 to $271.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Royal Bank Of Canada raised their price objective on Welltower from $238.00 to $260.00 and gave the stock an “outperform” rating in a report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft increased their target price on Welltower from $215.00 to $265.00 and gave the company a “buy” rating in a research note on Wednesday, July 1st. Citigroup lifted their price target on shares of Welltower from $255.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Finally, Evercore reiterated an “outperform” rating and set a $260.00 target price on shares of Welltower in a research note on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $251.06.

Welltower Company Profile

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.